CCXI To Face FDA In April, CRDF Soars On Colorectal Cancer Trial Data, VCNX In Deal With MRK

Today's Daily Dose brings you news about ChemoCentryx's regulatory catalyst in July, Checkpoint's $20 million bought deal offering, CytRx's potential milestone payment, Cardiff Oncology's encouraging colorectal cancer trial results, and Vaccinex's near-term catalyst.

from RTT - Biotech https://ift.tt/33BTaHX
via IFTTT